Production (Stage)
Beta Bionics, Inc.
BBNX
$14.43
-$1.08-6.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -130.19% | 3.93% | -- | ||
| Total Depreciation and Amortization | 7.28% | -2.76% | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 214.71% | -47.75% | -- | ||
| Change in Net Operating Assets | -32.60% | -472.97% | -- | ||
| Cash from Operations | -64.48% | -124.97% | -- | ||
| Capital Expenditure | 17.98% | -79.23% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -2,334.86% | 58.00% | -- | ||
| Cash from Investing | -2,443.30% | 57.39% | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 3,518,550.00% | 322.22% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 3,518,550.00% | 632,033.33% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 367.51% | 117.05% | -- | ||